New Claims for BioAstin Reviewed in the USA and Submitted in Europe 

26/10/07 BioAstin now has four new structure/function claims that have undergone US FDA review, and is currently applying for several more. In addition to this, the company has filed a formal petition in the European Union for six claims, which we it believes will be approved in the future. The claims focus on joint health, skin health, protection from UV damage, eye heath and immunity. 

“There are so many different benefits that people can derive from BioAstin; we’re very pleased that our customers in the USA can start listing them on their labels.  These approved claims, in conjunction with our three use patents for BioAstin, can help create a great marketing package for our customers,” said Cyanotech's Founder and CEO, Dr. Gerald Cysewski.  “We look forward to receiving the official approval for claims in Europe and other countries in the future.”